Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation
Condition(s):Cerebral Infarction; TIALast Updated:January 3, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Cerebral Infarction; TIALast Updated:January 3, 2024Recruiting
Condition(s):Atrial Fibrillation; StrokeLast Updated:June 27, 2011Completed
Condition(s):Post Cardiac Surgery Systemic Inflammatory ResponseLast Updated:July 16, 2014Unknown status
Condition(s):Venous Thromboembolism; Multiple MyelomaLast Updated:December 17, 2019Completed
Condition(s):Transient Ischemic Attack; Minor Ischemic StrokeLast Updated:January 30, 2019Completed
Condition(s):Atrial Fibrillation; Intracerebral HemorrhageLast Updated:August 21, 2023Recruiting
Condition(s):Atrial FibrillationLast Updated:September 21, 2022Not yet recruiting
Condition(s):Calciphylaxis; Calcific Uremic Arteriolopathy; End Stage Renal Disease; Chronic Kidney DiseasesLast Updated:October 18, 2023Recruiting
Condition(s):Deep Vein ThrombosisLast Updated:February 4, 2016Completed
Condition(s):Solid NeoplasmsLast Updated:May 22, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.